Big Pharma stockholders think so San Diego-based Vical, a firm who is developing an H1N1 vaccine under an agreement with the U.S. Navy saw company shares climb 45 cents, to $2.65 on positive clinical trial news this week. Vical researches and develops biopharmaceutical … [Read more...] about Is There an Upside to the Swine Flu Pandemic?